Huntleigh Advisors, Inc. Adma Biologics, Inc. Transaction History
Huntleigh Advisors, Inc.
- $518 Billion
- Q2 2025
A detailed history of Huntleigh Advisors, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 113,772 shares of ADMA stock, worth $1.66 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
113,772
Previous 109,616
3.79%
Holding current value
$1.66 Million
Previous $2.17 Billion
4.74%
% of portfolio
0.4%
Previous 0.51%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
403Shares Held
197MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$312 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$272 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$187 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86.3 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...